THEME: "Empowering Hearts, Empowering Lives: Shaping the Future of Cardiovascular Health"
15-16 Mar 2027
London, UK Delves into cellular mechanisms, molecular targets, and gene-editing approaches to treat heart disease.
Sub-topics:
CRISPR-Cas9 gene editing for inherited dyslipidemias and hypertrophic cardiomyopathies
Myocardial regeneration, stem cell therapies, and second heart field progenitor biology
Transcriptomics, epigenetics, and single-cell sequencing in atherogenesis and fibrosis